SESSION IX – Contrasting therapeutic concepts
Chairs: Jennifer Brown (Boston), Michael Hallek (Cologne)
14:45-14:50 Introduction Jennifer Brown (Boston)
Michael Hallek (Cologne)
14:50-15:05 MRD as a dynamic endpoint Peter Hillmen (Leeds)
15:05-15:20 Dynamic risk profiling using serial tumor biomarkers David M. Kurtz (Stanford)
for personalized outcome prediction in lymphoid
malignancies including CLL
15:20-15:35 Sequential vs combination treatments William Wierda (Houston)
15:35-15:50 Time limited vs continuous treatments Barbara Eichhorst (Cologne)
15:50-16:20 General discussion
16:20-16:30 Closing Remarks
MEETING CLOSURE
5
